Skip to main content
Elise Landais

Elise Landais

IAVI Neutralizing Antibody Center, United States

Elise Landais’ experience spans both T and B cell immunology, focusing on discovery and characterization of antigen-specific responses in collaboration with global partners.

Elise earned her PhD from INSERM in France and completed her postdoctoral studies at The Scripps Research Institute in California, USA. Since joining the International AIDS Vaccine Initiative (IAVI) in 2011, her work has focused on HIV and broadly neutralizing antibodies, both in natural infection in human and various immunization animal models to inform vaccine design. Leveraging her experience, she co-led the rapid isolation of COVID-19 antibodies in the early stages of the pandemic.

Elise now leads IAVI’s work in antibody research capacity building and strengthening in Africa and India through global partnerships to maximize global health impact.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.